Dec 7 Abbott Laboratories said on
Wednesday it had filed a complaint in the Delaware Court of
Chancery to terminate its proposed acquisition of Alere Inc
, citing a "substantial loss" in the value of the
Abbott agreed earlier this year to buy Alere for $5.8
billion, giving it access to Alere's diagnostic tests performed
at home and in doctors' offices and hospitals.
Alere has suffered a series of damaging business
developments in the 10 months following the signing of the
agreement, Abbott said.
(Reporting by Natalie Grover in Bengaluru; Editing by Ted Kerr)